Literature DB >> 10022620

Zinc therapy induction of intestinal metallothionein in Wilson's disease.

G J Brewer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10022620     DOI： 10.1111/j.1572-0241.1999.00301.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  3 in total

1.  Clinical efficacy of combined sodium dimercaptopropanesulfonate and zinc treatment in neurological Wilson's disease with D-penicillamine treatment failure.

Authors:  Dingbang Chen; Xiangxue Zhou; Haiman Hou; Li Feng; JunXiu Liu; Yinyin Liang; Xiaopu Lin; Jiwei Zhang; Chao Wu; Xiuling Liang; Zhong Pei; Xunhua Li
Journal:  Ther Adv Neurol Disord       Date:  2016-04-07       Impact factor: 6.570

2.  Elevated copper impairs hepatic nuclear receptor function in Wilson's disease.

Authors:  Clavia Ruth Wooton-Kee; Ajay K Jain; Martin Wagner; Michael A Grusak; Milton J Finegold; Svetlana Lutsenko; David D Moore
Journal:  J Clin Invest       Date:  2015-08-04       Impact factor: 14.808

3.  Zinc Maintenance Therapy for Wilson Disease: A Comparison Between Zinc Acetate and Alternative Zinc Preparations.

Authors:  Michelle A Camarata; Aftab Ala; Michael L Schilsky
Journal:  Hepatol Commun       Date:  2019-07-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.